UTHR

United Therapeutics
UTHR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$12.78B
EV
$7.95B
Shares Outstanding
47.65M
Beta
0.57

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$382.09
P/E 2025E
10.26x
P/Revenue 2025E
3.97x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About United Therapeutics Corporation

gainify
UTHR

United Therapeutics Corporation

UTHR

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offer...

Sector

Healthcare

Industry

Biotechnology

CEO

Rothblatt, Martine

Employees

1,305

IPO Date

1999-06-17

Headquarters

1000 Spring Street, Silver Spring, Maryland, 20910, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.